Semaphorin/Plexin Signaling Pathway in Neurodegeneration

Semaphorin/Plexin Signaling Pathway in Neurodegeneration

Overview

The Semaphorin/Plexin signaling pathway is a major axon guidance system critical for neural circuit formation, synaptic plasticity, and neuronal survival.[@unifying] Semaphorins are a large family of secreted and membrane-bound proteins that signal through Plexin receptors, regulating cytoskeletal dynamics, neurite outgrowth, and synaptic function throughout the central nervous system.[@disruption] Originally characterized for their roles in neural development, semaphorin/plexin signaling has emerged as an important pathway in neurodegenerative diseases including Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.[@semaphorin] [@unifying]

The pathway's dual roles in developmental axon guidance and adult synaptic plasticity make it a compelling target for understanding neurodegeneration and developing therapeutic interventions. [@disruption]

Pathway Diagram

Semaphorin Family

Class 3 Semaphorins (Secreted)

The Class 3 semaphorins are the primary secreted ligands for PlexinA receptors: [@semaphorin]

Semaphorin/Plexin Signaling Pathway in Neurodegeneration

Overview

The Semaphorin/Plexin signaling pathway is a major axon guidance system critical for neural circuit formation, synaptic plasticity, and neuronal survival.[@unifying] Semaphorins are a large family of secreted and membrane-bound proteins that signal through Plexin receptors, regulating cytoskeletal dynamics, neurite outgrowth, and synaptic function throughout the central nervous system.[@disruption] Originally characterized for their roles in neural development, semaphorin/plexin signaling has emerged as an important pathway in neurodegenerative diseases including Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.[@semaphorin] [@unifying]

The pathway's dual roles in developmental axon guidance and adult synaptic plasticity make it a compelling target for understanding neurodegeneration and developing therapeutic interventions. [@disruption]

Pathway Diagram

Semaphorin Family

Class 3 Semaphorins (Secreted)

The Class 3 semaphorins are the primary secreted ligands for PlexinA receptors: [@semaphorin]

SEMA3A (Semaphorin 3A): [@molecular]

• Highest affinity for PlexinA2 and PlexinA4
• Critical for cortical neuron migration
• Regulates hippocampal circuit formation
• Promotes growth cone collapse
• Involved in memory and learning

• Tumor suppressor functions
• Anti-angiogenic properties
• Regulates neuronal survival
• Altered in AD brain

• Coronary artery development
• Cortical neuron guidance
• Synaptic plasticity modulation
• Expressed in adult hippocampus

• Cardiac neural crest migration
• Axon guidance in sensory pathways
• Vascular development

• PlexinD1 as primary receptor
• Vascular patterning
• Motor neuron guidance
• Epithelial-mesenchymal transition

• High affinity for Neuropilin-2
• Potent axonal repulsion
• Tumor suppressor
• Hippocampal expression

Class 4-7 Semaphorins

Other semaphorin classes signal through different receptor combinations:

• SEMA4D (CD100) → PlexinB1 → Immune modulation, oligodendrocyte differentiation
• SEMA5A → PlexinB3 → Angiogenesis inhibition
• SEMA6A-6D → PlexinA2, PlexinA4 → Thalamic development
• SEMA7A → PlexinC1 → Inflammatory responses

Plexin Receptor Family

PlexinA Receptors

The PlexinA family (PlexinA1-A4) are the primary receptors for class 3 semaphorins:

PlexinA1 (PLXNA1):

• Expressed in developing and adult brain
• Mediates SEMA3A, SEMA3C signaling
• Regulates hippocampal synaptic plasticity
• Associates with Neuropilin-1/2

• High expression in cortex and hippocampus
• Primary receptor for SEMA3A and SEMA3F
• Critical for cortical neuron migration
• Involved in memory formation

• Expressed in excitatory neurons
• Mediates SEMA3A, SEMA3B, SEMA3C, SEMA3F
• Regulates synaptic transmission
• Important for sensory circuitry

• Particularly important in peripheral nervous system
• Sensory neuron function
• Pain signaling
• Auditory system development

PlexinB Receptors

PlexinB1 (PLXNB1):

• Binds SEMA4D
• Regulates immune cell function
• Modulates oligodendrocyte biology
• Involved in synaptic plasticity

Neuropilin Co-receptors

Neuropilin-1 (NRP1):

• Essential co-receptor for most SEMA3 ligands
• Enhances semaphorin binding affinity
• VEGF co-receptor for angiogenesis
• Expressed in neurons and vasculature

• Primary co-receptor for SEMA3F
• Expressed in hippocampal neurons
• Important for pain signaling
• Sensory neuron specification

Signaling Mechanisms

Forward Signaling (Plexin Receptor)

Upon semaphorin binding to Plexin receptors:

Downstream Pathways

Rho GTPase Family:

• R-Ras GAP activity — Inactivates R-Ras, promotes growth cone collapse
• RhoA activation — Regulates actomyosin contractility
• Rac1/Cdc42 — Modulates actin dynamics

• Cell survival signaling
• Anti-apoptotic effects
• Protein synthesis regulation

• Gene expression regulation
• Neuronal differentiation
• Synaptic plasticity

• Adhesion dynamics
• Growth cone motility
• Synapse formation

Neuropilin Enhancement

Neuropilins enhance signaling through:

• Increased ligand binding affinity
• Receptor clustering facilitation
• Alternative downstream pathway activation
• VEGF cross-talk

Cellular Effects

Neurite Outgrowth and Axon Guidance

During brain development:

• Growth cone collapse — SEMA3A induces rapid cytoskeletal collapse
• Axonal repulsion — Provides repulsive guidance cues
• Neuronal migration — Regulates cortical interneuron positioning
• Circuit formation — Establishes topographic maps

Synaptic Plasticity

In mature neurons:

• Dendritic spine morphology — SEMA3A regulates spine shape
• Synaptic transmission — Modulates excitatory/inhibitory balance
• Long-term potentiation — Involved in memory formation
• Synapse elimination — Regulates developmental pruning

Neuronal Survival

• Neuroprotective signaling — PI3K/Akt mediated survival
• Anti-apoptotic effects — Bcl-2 family regulation
• Metabolic support — VEGF cross-talk
• Stress response — Neuroprotection against toxins

Disease Involvement

Alzheimer's Disease

In Alzheimer's Disease, semaphorin/plexin signaling is dysregulated:[@semaphorin][@molecular]

| Evidence | Finding |
|----------|---------|
| Preclinical | SEMA3A levels elevated in AD hippocampus |
| Preclinical | PlexinA2 expression reduced in AD models |
| Preclinical | SEMA3A disrupts synaptic plasticity in Aβ models |
| Clinical | NRP1 genetic variants associated with AD risk |
| Clinical | Altered semaphorin signaling in AD brain tissue |

Key Mechanisms:

• Impaired SEMA3A signaling → synaptic plasticity deficits
• Dysregulated neurite outgrowth → neuronal connectivity loss
• Altered neuropilin expression → VEGF signaling disruption

Parkinson's Disease

In Parkinson's Disease, semaphorin/plexin affects dopaminergic neurons:[@molecular][@astrocytetomicroglia]

| Evidence | Finding |
|----------|---------|
| Preclinical | SEMA3A protects dopaminergic neurons from MPTP |
| Preclinical | PlexinA2 regulates dopaminergic axon guidance |
| Preclinical | NRP1 promotes dopaminergic neuron survival |
| Clinical | Altered SEMA3 expression in PD substantia nigra |
| Clinical | Semaphorin pathway genes in PD GWAS |

Key Mechanisms:

• Loss of semaphorin-mediated neuroprotection
• Impaired dopaminergic axon maintenance
• Dysregulated synaptic function in basal ganglia

Amyotrophic Lateral Sclerosis

In ALS, semaphorin/plexin influences motor neuron biology:[@astrocytetomicroglia][^6]

| Evidence | Finding |
|----------|---------|
| Preclinical | SEMA3A promotes motor neuron survival |
| Preclinical | PlexinA4 variants linked to ALS risk |
| Preclinical | SEMA3A at neuromuscular junction |
| Clinical | Altered semaphorin expression in ALS spinal cord |
| Clinical | Neuropilin dysregulation in ALS motor cortex |

Key Mechanisms:

• Aberrant semaphorin signaling in motor neurons
• Impaired axonal regeneration capacity
• Dysregulated synaptic maintenance at NMJ

Stroke and Traumatic Brain Injury

• Axonal regeneration — Semaphorins as inhibitory molecules
• Glial scarring — Modulates astrocyte response
• Rehabilitation — Enhancing semaphorin signaling may improve recovery
• Angiogenesis — NRP1/VEGF cross-talk in vascular remodeling

Therapeutic Targeting

Semaphorin/plexin pathway modulators are being investigated for neuroprotective therapies.[^9]

Semaphorin-Based Therapies

Agonists and Activators:

• Recombinant semaphorin proteins
• SEMA3A-Fc fusion proteins
• Gene therapy for semaphorin expression
• Small molecule activators

• Soluble Plexin extracellular domains
• Blocking antibodies against SEMA3 or Plexin
• Peptide antagonists
• Decoy receptors

Plexin-Based Therapies

Modulators:

• Plexin cytoplasmic domain inhibitors
• GAP domain modulators
• Kinase inhibitors targeting downstream pathways

Clinical Status

| Target | Approach | Development Stage |
|--------|----------|-------------------|
| SEMA3A | Recombinant protein | Preclinical |
| SEMA3F | Gene therapy | Preclinical |
| PlexinA2 | Small molecule modulators | Preclinical |
| NRP1 | Blocking antibodies | Phase I (cancer) |
| NRP1/NRP2 | Dual antagonists | Preclinical |

Repurposing Opportunities

• Cardiovascular drugs — Some vasopressors affect semaphorin signaling
• Cancer therapeutics — Anti-NRP1 antibodies in development
• Immunomodulators — SEMA4D antagonists for autoimmunity

Cross-Links to Related Pathways

• [Axon Guidance Signaling](/mechanisms/axon-guidance)
• [Netrin Signaling Pathway](/mechanisms/netrin-signaling)
• [Ephrin/Eph Receptor Signaling](/mechanisms/ephrin-ephr-signaling)
• [CXCL12/CXCR4 Signaling](/genes/cxcl1)
• [Slit](/mechanisms/dopaminergic-neuron-vulnerability)
• [PI3K/Akt Signaling Pathway](/mechanisms/dopaminergic-neuron-vulnerability)
• [Rho GTPase Signaling](/mechanisms/dopaminergic-neuron-vulnerability)
• [Synaptic Plasticity Signaling](/mechanisms/dopaminergic-neuron-vulnerability)
• [VEGF Signaling Pathway](/mechanisms/dopaminergic-neuron-vulnerability)

Related Gene and Protein Pages

• PLXNA1 Gene — Major semaphorin receptor
• PLXNA1 Protein — PlexinA1 receptor protein
• PLXNA2 Gene — Cortical development receptor
• PLXNA2 Protein — PlexinA2 receptor protein
• PLXNA3 Gene — Synaptic plasticity receptor
• PLXNA3 Protein — PlexinA3 receptor protein
• PLXNA4 Gene — Sensory function receptor
• PLXNA4 Protein — PlexinA4 receptor protein

Summary

The Semaphorin/Plexin signaling pathway represents a fundamental axon guidance system essential for nervous system development and function. Through its complex repertoire of ligands (SEMA3A-F and other classes) and receptors (PlexinA/B family with Neuropilin co-receptors), this pathway regulates neurite outgrowth, axon guidance, synaptic formation, and neuronal survival. In neurodegenerative diseases, dysregulation of semaphorin/plexin signaling contributes to pathology through impaired synaptic plasticity, reduced neuroprotection, and altered neuronal connectivity. The pathway's involvement in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis makes it an attractive target for therapeutic intervention. Understanding the spatiotemporal dynamics of semaphorin/plexin signaling and its interactions with other guidance systems provides opportunities for developing neuroprotective strategies.

Recent Research Updates (2024-2026)

This section highlights recent publications relevant to this mechanism.

• [A unifying mechanism for presynaptic homeostatic plasticity at mammalian peripheral and central synapses.](https://pubmed.ncbi.nlm.nih.gov/40592327/) (2025 Sep 17) - Neuron
• [Disruption of Plexin-A1 signaling by FTX-101: mode of action and effect on oligodendrocyte biology.](https://pubmed.ncbi.nlm.nih.gov/40435840/) (2025 Jul) - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
• [Semaphorin 3s signaling in the central nervous system: Mechanisms and therapeutic implication for brain diseases.](https://pubmed.ncbi.nlm.nih.gov/39855276/) (2025 Mar) - Pharmacology & therapeutics
• [Molecular mechanisms of proteoglycan-mediated semaphorin signaling in axon guidance.](https://pubmed.ncbi.nlm.nih.gov/39042673/) (2024 Jul 30) - Proceedings of the National Academy of Sciences of the United States of America
• [Astrocyte-to-microglia communication via Sema4B-Plexin-B2 modulates injury-induced reactivity of microglia.](https://pubmed.ncbi.nlm.nih.gov/38781210/) (2024 May 28) - Proceedings of the National Academy of Sciences of the United States of America

References

See Also

• [P](/mechanisms/dopaminergic-neuron-vulnerability)
• [Parkinson's Disease Mechanisms](/mechanisms/parkinsons-disease-mechanisms)
• [Amyotrophic Lateral Sclerosis Mechanisms](/diseases/amyotrophic-lateral-sclerosis)
• [Axon Guidance](/cell-types/waddington-axon-guidance)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Cell Types](/cell-types)